Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 68277Q105 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Coastlands Capital LP
13G
|
6.7% |
10/7/2026
Event 10/1/2026
|
|
| Coastlands Capital LP | 6.7% | ||
| Coastlands Capital Partners LP | 6.7% | ||
| Coastlands Capital GP LLC | 6.7% | ||
| Coastlands Capital LLC | 6.7% | ||
| Matthew D. Perry | 6.7% | ||
|
ADAR1 Capital Management, LLC
13G/A
Amendment 2
|
5.5%
Checked 5% or less
|
8/14/2026
Event 6/30/2026
|
|
| ADAR1 Capital Management, LLC | 5.5% | ||
| ADAR1 Capital Management GP, LLC | 4.5% | ||
| Daniel Schneeberger | 5.5% | ||
|
Biotechnology Value Fund L P
13G/A
Amendment 1
|
8.0% |
8/14/2026
Event 6/30/2026
|
|
| Biotechnology Value Fund L P | 4.1% | ||
| BVF I GP LLC | 4.1% | ||
| Biotechnology Value Fund II LP | 3.2% | ||
| BVF II GP LLC | 3.2% | ||
| Biotechnology Value Trading Fund OS LP | 0.6% | ||
| BVF Partners OS Ltd. | 0.6% | ||
| BVF GP Holdings LLC | 7.3% | ||
| BVF Partners L P/IL | 8.0% | ||
| BVF Inc/IL | 8.0% | ||
| Lampert Mark N | 8.0% | ||
|
Prosight Management, LP
13G/A
Amendment 1
|
2.4% |
8/10/2026
Event 6/30/2026
|
|
| Prosight Management, LP | 2.4% | ||
| Prosight Fund, LP | 0.1% | ||
| Prosight Plus Fund, LP | 0.5% | ||
| Prosight Partners, LLC | 2.4% | ||
| W. Lawrence Hawkins | 2.4% | ||
|
Biotechnology Value Fund L P
13G
|
5.3% |
5/27/2026
Event 5/19/2026
|
|
| Biotechnology Value Fund L P | 2.7% | ||
| BVF I GP LLC | 2.7% | ||
| Biotechnology Value Fund II LP | 2.1% | ||
| BVF II GP LLC | 2.1% | ||
| Biotechnology Value Trading Fund OS LP | 0.4% | ||
| BVF Partners OS Ltd. | 0.4% | ||
| BVF GP Holdings LLC | 4.8% | ||
| BVF Partners L P/IL | 5.3% | ||
| BVF Inc/IL | 5.3% | ||
| Lampert Mark N | 5.3% | ||
|
ADAR1 Capital Management, LLC
13G/A
Amendment 1
|
6.0% |
5/15/2026
Event 3/31/2026
|
|
| ADAR1 Capital Management, LLC | 6.0% | ||
| ADAR1 Capital Management GP, LLC | 5.0% | ||
| Daniel Schneeberger | 6.0% | ||
|
Trails Edge Capital Partners, LP
13G
|
6.0% |
4/7/2026
Event 3/31/2026
|
|
| Trails Edge Capital Partners, LP | 6.0% | ||
| Trails Edge Biotechnology Master Fund, LP | 6.0% | ||
| Ortav Yehudai | 6.0% | ||
|
RA Capital Management, L.P.
13G
|
9.9% |
4/7/2026
Event 3/31/2026
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 9.9% | ||
|
AI Biotechnology LLC
13D
|
20.0% |
4/7/2026
Event 3/31/2026
|
|
| AI Biotechnology LLC | 20.0% | ||
| Access Industries Holdings LLC | 20.0% | ||
| Access Industries Management, LLC | 20.0% | ||
| Len Blavatnik | 20.0% | ||
|
StepStone Group LP
13G
|
6.6% |
4/7/2026
Event 3/31/2026
|
|
| StepStone Group LP | 6.6% | ||
| StepStone Master G, L.P. | 6.6% | ||
| StepStone VC MI-G GP, LLC | 6.6% | ||
|
Acorn Bioventures, L.P.
13G
|
9.5% |
4/1/2026
Event 3/27/2026
|
|
| Acorn Bioventures, L.P. | 4.5% | ||
| Acorn Capital Advisors GP, LLC | 4.5% | ||
| Acorn Bioventures 2, L.P. | 5.0% | ||
| Acorn Capital Advisors GP 2, LLC | 5.0% | ||
| Anders Hove | 9.5% | ||
|
ADAR1 Capital Management, LLC
13G
|
7.9% |
2/17/2026
Event 12/31/2025
|
|
| ADAR1 Capital Management, LLC | 7.9% | ||
| ADAR1 Capital Management GP, LLC | 6.2% | ||
| Daniel Schneeberger | 7.9% | ||
|
Citadel Advisors LLC
13G/A
Amendment 1
|
1.7% |
2/17/2026
Event 12/31/2025
|
|
| Citadel Advisors LLC | 0.4% | ||
| Citadel Advisors Holdings LP | 0.4% | ||
| Citadel GP LLC | 0.4% | ||
| Citadel Securities LLC | 1.4% | ||
| Citadel Securities Group LP | 1.4% | ||
| Citadel Securities GP LLC | 1.4% | ||
| Kenneth Griffin | 1.7% | ||
| Highbridge Capital Management, LLC 13G/A Amendment 1 | 4.2% |
2/17/2026
Event 12/31/2025
|
|
| Vanguard Group Inc 13G/A Amendment 1 | 4.9% |
1/30/2026
Event 12/31/2025
|
|
|
Prosight Management, LP
13G
|
5.8% |
11/28/2025
Event 11/24/2025
|
|
| Prosight Management, LP | 5.8% | ||
| Prosight Fund, LP | 0.3% | ||
| Prosight Plus Fund, LP | 1.3% | ||
| Prosight Partners, LLC | 5.8% | ||
| W. Lawrence Hawkins | 5.8% | ||
|
Samsara BioCapital, L.P.
13G/A
Amendment 1
|
0% |
8/14/2025
Event 6/30/2025
|
|
| Samsara BioCapital, L.P. | 0% | ||
| Samsara BioCapital GP, LLC | 0% | ||
| Srinivas Akkaraju | 0% | ||
|
Cantor Fitzgerald & Co.
13G
|
5.2% |
8/14/2025
Event 6/30/2025
|
|
| Cantor Fitzgerald Securities | 5.2% | ||
| Cantor Fitzgerald & Co. | 5.2% | ||
| Cantor Fitzgerald, L.P. | 5.2% | ||
| CF Group Management, Inc. | 5.2% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 1
|
0% |
8/14/2025
Event 6/30/2025
|
|
| Perceptive Advisors LLC | |||
| Joseph Edelman | 0% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 0% | ||
| Highbridge Capital Management, LLC 13G | 5.2% |
8/14/2025
Event 6/30/2025
|
|
|
Acorn Bioventures, L.P.
13D/A
Amendment 1
|
22.1% |
5/30/2025
Event 5/15/2025
|
|
| Acorn Bioventures, L.P. | 13.3% | ||
| Acorn Capital Advisors GP, LLC | 13.3% | ||
| Anders Hove | 22.1% | ||
| Acorn Bioventures 2, L.P. | 8.8% | ||
| Acorn Capital Advisors GP 2, LLC | 8.8% | ||
|
Shay Capital LLC
13G
|
6.3% |
5/29/2025
Event 5/15/2025
|
|
| Shay Capital LLC | 6.3% | ||
| Shay Capital Holdings LLC | 6.3% | ||
|
Acorn Bioventures, L.P.
13D
|
22.1% |
5/22/2025
Event 5/15/2025
|
|
| Acorn Bioventures, L.P. | 13.3% | ||
| Acorn Capital Advisors GP, LLC | 13.3% | ||
| Anders Hove | 22.1% | ||
| Acorn Bioventures 2, L.P. | 8.8% | ||
| Acorn Capital Advisors GP 2, LLC | 8.8% | ||
|
Cormorant Asset Management, LP
13G/A
Amendment 2
|
0% |
5/19/2025
Event 5/15/2025
|
|
| Cormorant Asset Management, LP | 0% | ||
| Bihua Chen | 0% | ||
|
Deep Track Capital, LP
13G/A
Amendment 2
|
4.1% |
2/14/2025
Event 12/31/2024
|
|
| Deep Track Capital, LP | 4.1% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 4.1% | ||
| David Kroin | 4.1% | ||
| Highbridge Capital Management, LLC 13G/A Amendment 1 | 3.2% |
2/7/2025
Event 12/31/2024
|
|
|
Lundbeckfond Invest A/S
13G/A
Amendment 1
|
1.6% |
2/6/2025
Event 12/31/2024
|
|
| Lundbeckfond Invest A/S | 1.6% | ||
| Lene Skole | 1.6% | ||
| Vanguard Group Inc 13G | 5.6% |
1/31/2025
Event 12/31/2024
|